22-37069345-CTGGGGTGGGGTGGGGTGGGG-CTGGGGTGGGGTGGGG

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 4P and 16B. PVS1_StrongBP6_Very_StrongBA1

The NM_001374504.1(TMPRSS6):​c.1842-6_1842-2delCCCCA variant causes a splice acceptor, splice region, intron change. The variant allele was found at a frequency of 0.358 in 416,978 control chromosomes in the GnomAD database, including 28,314 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 8919 hom., cov: 0)
Exomes 𝑓: 0.32 ( 19395 hom. )

Consequence

TMPRSS6
NM_001374504.1 splice_acceptor, splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 5.94

Publications

2 publications found
Variant links:
Genes affected
TMPRSS6 (HGNC:16517): (transmembrane serine protease 6) The protein encoded by this gene is a type II transmembrane serine proteinase that is found attached to the cell surface. The encoded protein may be involved in matrix remodeling processes in the liver. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
TMPRSS6 Gene-Disease associations (from GenCC):
  • IRIDA syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.11290992 fraction of the gene. Cryptic splice site detected, with MaxEntScore 3.8, offset of 0 (no position change), new splice context is: cccaccccaccccaccccAGcat. Cryptic site results in inframe change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
BP6
Variant 22-37069345-CTGGGG-C is Benign according to our data. Variant chr22-37069345-CTGGGG-C is described in ClinVar as [Benign]. Clinvar id is 262724.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.53 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMPRSS6NM_001374504.1 linkc.1842-6_1842-2delCCCCA splice_acceptor_variant, splice_region_variant, intron_variant Intron 15 of 17 ENST00000676104.1 NP_001361433.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMPRSS6ENST00000676104.1 linkc.1842-6_1842-2delCCCCA splice_acceptor_variant, splice_region_variant, intron_variant Intron 15 of 17 NM_001374504.1 ENSP00000501573.1 Q8IU80-1

Frequencies

GnomAD3 genomes
AF:
0.510
AC:
46241
AN:
90652
Hom.:
8915
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.525
Gnomad AMI
AF:
0.515
Gnomad AMR
AF:
0.461
Gnomad ASJ
AF:
0.509
Gnomad EAS
AF:
0.550
Gnomad SAS
AF:
0.404
Gnomad FIN
AF:
0.591
Gnomad MID
AF:
0.536
Gnomad NFE
AF:
0.501
Gnomad OTH
AF:
0.502
GnomAD2 exomes
AF:
0.220
AC:
16145
AN:
73502
AF XY:
0.216
show subpopulations
Gnomad AFR exome
AF:
0.287
Gnomad AMR exome
AF:
0.175
Gnomad ASJ exome
AF:
0.268
Gnomad EAS exome
AF:
0.230
Gnomad FIN exome
AF:
0.265
Gnomad NFE exome
AF:
0.211
Gnomad OTH exome
AF:
0.248
GnomAD4 exome
AF:
0.316
AC:
102986
AN:
326256
Hom.:
19395
AF XY:
0.322
AC XY:
54514
AN XY:
169448
show subpopulations
African (AFR)
AF:
0.285
AC:
2789
AN:
9786
American (AMR)
AF:
0.232
AC:
2820
AN:
12174
Ashkenazi Jewish (ASJ)
AF:
0.401
AC:
3545
AN:
8850
East Asian (EAS)
AF:
0.558
AC:
8106
AN:
14528
South Asian (SAS)
AF:
0.328
AC:
8685
AN:
26452
European-Finnish (FIN)
AF:
0.431
AC:
9861
AN:
22898
Middle Eastern (MID)
AF:
0.298
AC:
479
AN:
1608
European-Non Finnish (NFE)
AF:
0.284
AC:
60931
AN:
214842
Other (OTH)
AF:
0.382
AC:
5770
AN:
15118
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
3031
6061
9092
12122
15153
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.510
AC:
46265
AN:
90722
Hom.:
8919
Cov.:
0
AF XY:
0.509
AC XY:
21831
AN XY:
42930
show subpopulations
African (AFR)
AF:
0.524
AC:
13954
AN:
26610
American (AMR)
AF:
0.461
AC:
3269
AN:
7094
Ashkenazi Jewish (ASJ)
AF:
0.509
AC:
1132
AN:
2222
East Asian (EAS)
AF:
0.551
AC:
1841
AN:
3344
South Asian (SAS)
AF:
0.405
AC:
820
AN:
2024
European-Finnish (FIN)
AF:
0.591
AC:
3124
AN:
5284
Middle Eastern (MID)
AF:
0.544
AC:
99
AN:
182
European-Non Finnish (NFE)
AF:
0.501
AC:
21180
AN:
42284
Other (OTH)
AF:
0.499
AC:
571
AN:
1144
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1303
2606
3908
5211
6514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.192
Hom.:
675

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 3449/7484=46.08% -

Microcytic anemia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
5.9
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60484081; hg19: chr22-37465385; COSMIC: COSV60977486; API